The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease

被引：250

作者：

Hur, Ji-Yeun ^{[1
]}

Frost, Georgia R. ^{[1
,2
]}

Wu, Xianzhong ^{[1
]}

Crump, Christina ^{[1
,3
]}

Pan, Si Jia ^{[1
]}

Wong, Eitan ^{[1
]}

Barros, Marilia ^{[1
]}

Li, Thomas ^{[1
,2
]}

Nie, Pengju ^{[1
,3
]}

Zhai, Yujia ^{[1
]}

Wang, Jen Chyong ^{[4
]}

TCW, Julia ^{[4
]}

Guo, Lei ^{[5
]}

McKenzie, Andrew ^{[5
]}

Ming, Chen ^{[5
]}

Zhou, Xianxiao ^{[5
]}

Wang, Minghui ^{[5
]}

Sagi, Yotam ^{[6
]}

Renton, Alan E. ^{[4
]}

Esposito, Bianca T. ^{[4
]}

Kim, Yong ^{[6
]}

Sadleir, Katherine R. ^{[7
]}

Trinh, Ivy ^{[8
]}

Rissman, Robert A. ^{[8
]}

Vassar, Robert ^{[7
]}

Zhang, Bin ^{[5
]}

Johnson, Douglas S. ^{[9
]}

Masliah, Eliezer ^{[8
]}

Greengard, Paul ^{[6
]}

Goate, Alison ^{[4
,5
]}

Li, Yue-Ming ^{[1
,2
,3
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Chem Biol Program, 1275 York Ave, New York, NY 10021 USA

[2] Cornell Univ, Program Neurosci, Weill Grad Sch Med Sci, New York, NY USA

[3] Cornell Univ, Weill Grad Sch Med Sci, Program Pharmacol, New York, NY 10021 USA

[4] Icahn Sch Med Mt Sinai, Dept Neurosci, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA

[5] Icahn Sch Med Mt Sinai, Mt Sinai Ctr Transformat Dis Modeling, Dept Genet & Genom Sci, New York, NY 10029 USA

[6] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY USA

[7] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[8] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA

[9] Pfizer Worldwide Res & Dev, Cambridge, MA USA

来源：

NATURE | 2020年 / 586卷 / 7831期

基金：

美国国家卫生研究院;

关键词：

DETERGENT-RESISTANT MEMBRANES; INHIBITORS; RISK; PRESENILIN-1; ASSOCIATION; ACTIVATION; MUTATIONS; REVEALS; NEURONS; BINDING;

D O I：

10.1038/s41586-020-2681-2

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The IFITM3 innate immunity protein directly binds presenilin near the active site and upregulates gamma-secretase activity and the production of amyloid-beta, and IFITM3 is upregulated in patients with late-onset Alzheimer's disease. Innate immunity is associated with Alzheimer's disease(1), but the influence of immune activation on the production of amyloid-beta is unknown(2,3). Here we identify interferon-induced transmembrane protein 3 (IFITM3) as a gamma-secretase modulatory protein, and establish a mechanism by which inflammation affects the generation of amyloid-beta. Inflammatory cytokines induce the expression of IFITM3 in neurons and astrocytes, which binds to gamma-secretase and upregulates its activity, thereby increasing the production of amyloid-beta. The expression of IFITM3 is increased with ageing and in mouse models that express familial Alzheimer's disease genes. Furthermore, knockout of IFITM3 reduces gamma-secretase activity and the formation of amyloid plaques in a transgenic mouse model (5xFAD) of early amyloid deposition. IFITM3 protein is upregulated in tissue samples from a subset of patients with late-onset Alzheimer's disease that exhibit higher gamma-secretase activity. The amount of IFITM3 in the gamma-secretase complex has a strong and positive correlation with gamma-secretase activity in samples from patients with late-onset Alzheimer's disease. These findings reveal a mechanism in which gamma-secretase is modulated by neuroinflammation via IFITM3 and the risk of Alzheimer's disease is thereby increased.

引用

页码：735 / +

页数：16

共 50 条

[41] β-Secretase-1: In Silico Drug Reposition for Alzheimer's Disease
Galeana-Ascencio, Roberto A.
Mendieta, Liliana
Limon, Daniel I.
Gnecco, Dino
Teran, Joel L.
Orea, Maria L.
Carrasco-Carballo, Alan
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
[42] Oral Glucose Loading Modulates Plasma β-Amyloid Level in Alzheimer's Disease Patients: Potential Diagnostic Method for Alzheimer's Disease
Takeda, Shuko
Sato, Naoyuki
Uchio-Yamada, Kozue
Yu, Hisahiro
Moriguchi, Atsushi
Rakugi, Hiromi
Morishita, Ryuichi
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 34 (01) : 25 - 30
[43] Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease
Pandey, Janardan P.
Kothera, Ronald T.
Liu, Shufeng
Costa, Andrea Saul
Mancuso, Roberta
Agostini, Simone
JOURNAL OF ALZHEIMERS DISEASE, 2019, 70 (03) : 917 - 924
[44] Secretase Inhibitors and Modulators as a Disease-Modifying Approach Against Alzheimer's Disease
Gijsen, Harrie J. M.
Bischoff, Francois P.
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47, 2012, 47 : 55 - 69
[45] Central and peripheral innate and adaptive immunity in Parkinson's disease
Harms, Ashley S.
Yang, Ya-Ting
Tansey, Malu Gamez
SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (721)
[46] Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
Shi, Yang
Holtzman, David M.
NATURE REVIEWS IMMUNOLOGY, 2018, 18 (12) : 759 - 772
[47] Alzheimer's Disease: The Role of Mutations in Protein Folding
Polychronidou, Eleftheria
Avramouli, Antigoni
Vlamos, Panayiotis
GENEDIS 2018: GENETICS AND NEURODEGENERATION, 2020, 1195 : 227 - 236
[48] γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease
Serneels, Lutgarde
Van Biervliet, Jerome
Craessaerts, Katleen
Dejaegere, Tim
Horre, Katrien
Van Houtvin, Tine
Esselmann, Hermann
Paul, Sabine
Schaefer, Martin K.
Berezovska, Oksana
Hyman, Bradley T.
Sprangers, Ben
Sciot, Raf
Moons, Lieve
Jucker, Mathias
Yang, Zhixiang
May, Patrick C.
Karran, Eric
Wiltfang, Jens
D'Hooge, Rudi
De Strooper, Bart
SCIENCE, 2009, 324 (5927) : 639 - 642
[49] Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments
Dowjat, WK
Wisniewski, H
Wisniewski, T
NEUROSCIENCE, 2001, 103 (01) : 1 - 8
[50] γ-Secretase as a drug target for familial Alzheimer's disease: the road less traveled
Wolfe, Michael S.
FUTURE MEDICINAL CHEMISTRY, 2022, 14 (19) : 1341 - 1343

← 1 2 3 4 5 →